CIK 0001604821 · Large accelerated filer
Natera, Inc.
Sign in to watch- Ticker
- NTRA
- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 010894487
- Phone
- 650-249-9090
- Business address
- 13011 MCCALLEN PASS, BUILDING A SUITE 100, AUSTIN, TX, 78753
- Former names
- Natera, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $104,832,418
- in 28 filings, $104.8M under 10b5-1 plans
Net −$104,832,418. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Rabinowitz Matthew −$72.3M EXECUTIVE CHAIRMAN sold 9% of stake
- Sheena Jonathan −$13.8M Director sold 83% of stake
- Moshkevich Solomon −$9.5M PRESIDENT, CLINICALDIAGNOSTICS sold 21% of stake
- Chapman Steven Leonard −$5.0M CEO AND PRESIDENT sold 12% of stake
- Brophy Michael Burkes −$2.5M CHIEF FINANCIAL OFFICER sold 11% of stake
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-07-28 | Brophy Michael Burkes CHIEF FINANCIAL OFFICER | Sale 10b5-1 | −1,241 | $254.07 | $315K | 55,473 |
| 2026-07-28 | Brophy Michael Burkes CHIEF FINANCIAL OFFICER | Sale 10b5-1 | −1,008 | $253.77 | $256K | 54,465 |
| 2026-07-28 | Brophy Michael Burkes CHIEF FINANCIAL OFFICER | Sale 10b5-1 | −170 | $254.33 | $43K | 54,295 |
| 2026-07-28 | Sheena Jonathan Director | Sale 10b5-1 | −191 | $254.07 | $49K | 245,723 |
| 2026-07-27 | Fesko John PRESIDENT, CHIEF BUS. OFFICER | Sale 10b5-1 | −782 | $260.49 | $204K | 185,000 |
| 2026-07-27 | Moshkevich Solomon PRESIDENT, CLINICALDIAGNOSTICS | Sale 10b5-1 | −1,010 | $260.49 | $263K | 133,633 |
| 2026-07-27 | RABINOWITZ DANIEL SEC. AND CHIEF LEGAL OFFICER | Sale 10b5-1 | −884 | $260.49 | $230K | 171,410 |
| 2026-07-27 | Chapman Steven Leonard CEO AND PRESIDENT | Sale 10b5-1 | −2,190 | $260.49 | $570K | 106,553 |
| 2026-07-27 | Brophy Michael Burkes CHIEF FINANCIAL OFFICER | Sale 10b5-1 | −782 | $260.49 | $204K | 56,714 |
| 2026-07-27 | Sheena Jonathan Director | Sale 10b5-1 | −288 | $260.49 | $75K | 245,914 |
| 2026-07-27 | Rabinowitz Matthew EXECUTIVE CHAIRMAN | Sale 10b5-1 | −1,718 | $260.49 | $448K | 2,276,125 |
| 2026-07-15 | Chapman Rowan E Director | Sale 10b5-1 | −135 | $274.82 | $37K | 4,663 |
| 2026-07-15 | Sheena Jonathan Director | Sale 10b5-1 | −450 | $273.05 | $123K | 18,332 |
| 2026-07-15 | Sheena Jonathan Director | Sale 10b5-1 | −90 | $274.26 | $25K | 18,242 |
| 2026-07-15 | Sheena Jonathan Director | Sale 10b5-1 | −170 | $275.26 | $47K | 18,072 |
| 2026-07-15 | Sheena Jonathan Director | Sale 10b5-1 | −40 | $276.38 | $11K | 18,032 |
| 2026-07-15 | Sheena Jonathan Director | Sale 10b5-1 | −390 | $273.01 | $106K | 18,392 |
| 2026-07-15 | Sheena Jonathan Director | Sale 10b5-1 | −100 | $273.68 | $27K | 18,292 |
| 2026-07-15 | Sheena Jonathan Director | Sale 10b5-1 | −180 | $274.99 | $49K | 18,112 |
| 2026-07-15 | Sheena Jonathan Director | Sale 10b5-1 | −80 | $276.02 | $22K | 18,032 |
Page 12 of 39 · 767 trades